These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1651950)

  • 1. Characterization of hepatitis A virus capsid proteins with antisera raised to recombinant antigens.
    Ross BC; Anderson DA
    J Virol Methods; 1991 May; 32(2-3):213-20. PubMed ID: 1651950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response.
    Gauss-Müller V; Zhou MQ; von der Helm K; Deinhardt F
    J Med Virol; 1990 Aug; 31(4):277-83. PubMed ID: 2176673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli.
    Johnston JM; Harmon SA; Binn LN; Richards OC; Ehrenfeld E; Summers DF
    J Infect Dis; 1988 Jun; 157(6):1203-11. PubMed ID: 2836522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Coxsackievirus B4 proteins VP0 and 2C in Escherichia coli and generation of virus protein recognizing antisera.
    Härkönen T; Hovi T; Roivainen M
    J Virol Methods; 1997 Dec; 69(1-2):147-58. PubMed ID: 9504760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic priming with recombinant hepatitis A virus capsid proteins produced in Escherichia coli.
    Powdrill TF; Johnston JM
    J Virol; 1991 May; 65(5):2686-90. PubMed ID: 1850041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hepatitis A virus proteins in infected BS-C-1 cells.
    Updike WS; Tesar M; Ehrenfeld E
    Virology; 1991 Nov; 185(1):411-8. PubMed ID: 1656592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of coxsackievirus B3 capsid proteins in Escherichia coli and generation of virus-specific antisera.
    Werner S; Klump WM; Schönke H; Hofschneider PH; Kandolf R
    DNA; 1988 Jun; 7(5):307-16. PubMed ID: 2841081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to hepatitis A virus capsid proteins after infection.
    Wang CH; Tschen SY; Heinricy U; Weber M; Flehmig B
    J Clin Microbiol; 1996 Mar; 34(3):707-13. PubMed ID: 8904442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a hepatitis A virus strain suitable for vaccine production.
    Fineschi N; Cavalieri F; Garelick H; Prugnola A; Pellegrini V; Zuckerman AJ
    J Hepatol; 1991; 13 Suppl 4():S146-51. PubMed ID: 1668326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression in Escherichia coli of the major outer capsid protein of infectious pancreatic necrosis virus.
    Lawrence WR; Nagy E; Duncan R; Krell P; Dobos P
    Gene; 1989 Jul; 79(2):369-74. PubMed ID: 2507397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity of human and rabbit antisera to hepatitis A virus.
    Gauss-Müller V; Deinhardt F
    J Med Virol; 1988 Feb; 24(2):219-28. PubMed ID: 2832540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hepatitis A virus cDNA in Escherichia coli: antigenic VP1 recombinant protein.
    Ostermayr R; von der Helm K; Gauss-Müller V; Winnacker EL; Deinhardt F
    J Virol; 1987 Nov; 61(11):3645-7. PubMed ID: 2822970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prokaryotic expression of the major capsid protein of human cytomegalovirus and antigenic cross-reactions with herpes simplex virus type 1.
    Rudolph SA; Kühn JE; Korn K; Braun RW; Jahn G
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():2023-31. PubMed ID: 2170571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the hepatitis A virion: peptide mapping of the capsid region.
    Wheeler CM; Robertson BH; Van Nest G; Dina D; Bradley DW; Fields HA
    J Virol; 1986 May; 58(2):307-13. PubMed ID: 3009847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodetection of Canine Parvovirus (CPV) in clinical samples by polyclonal antisera against CPV-VP2 protein expressed in Esherichia coli as an antigen.
    Park JS; Choi BK; Vijayachandran LS; Ayyappan V; Chong CK; Lee KS; Kim SC; Choi CW
    J Virol Methods; 2007 Dec; 146(1-2):281-7. PubMed ID: 17825928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of an antigenic polypeptide of the human parvovirus B19.
    Eiffert H; Köchel HG; Heuer M; Tratschin JD; Thomssen R
    Med Microbiol Immunol; 1990; 179(4):169-75. PubMed ID: 2175835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles.
    Anderson DA; Ross BC
    J Virol; 1990 Nov; 64(11):5284-9. PubMed ID: 2170672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and localization of the 'common antigen' region.
    Strike DG; Bonnez W; Rose RC; Reichman RC
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():543-55. PubMed ID: 2471790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topology and immunoreactivity of capsid proteins in hepatitis A virus.
    Gerlich WH; Frösner GG
    Med Microbiol Immunol; 1983; 172(2):101-6. PubMed ID: 6310355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterization.
    Banks L; Matlashewski G; Pim D; Churcher M; Roberts C; Crawford L
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3081-9. PubMed ID: 2826650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.